Related Experiment Video
Updated: Mar 17, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Antisense Molecules: Design, Chemistry, and Therapeutic Innovations
Prema Vediappan1, Swetha Aravamudhan2, Jocelyn Olivia Prabhakar David2
1Department of Pharmaceutical Chemistry, K.K. College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Chennai, Tamil Nadu, India.
Introduction:
Antisense molecules are short synthetic nucleic acid strands designed to bind to complementary sequences of messenger RNA (mRNA) to regulate gene expression. This study focuses on understanding the chemistry, modifications, and therapeutic applications of antisense molecules.
Method:
A comprehensive literature review was conducted using scientific databases, including PubMed, Scopus, and Google Scholar. Relevant published articles were selected using keywords such as "antisense oligonucleotides," "gene silencing," "therapeutic applications," "neurological disorders," and "cancer." Studies included in this review consisted of research focusing on the mechanisms, delivery methods, and therapeutic outcomes of antisense oligonucleotides.
Result:
The data obtained in this study indicate that third-generation ASOs exhibit greater therapeutic efficacy than first- and second-generation ASOs.
Discussion:
This review compiles and discusses the mechanisms of action, structural features, chemical modifications, recent advances, applications, challenges, and future directions of ASOs in genetic disorders and other diseases.
Conclusion:
Antisense oligonucleotides (ASOs) have been successfully approved by the FDA for the development of drugs such as Nusinersen (used for the treatment of spinal muscular atrophy) and Fomivirsen (used for treating Cytomegalovirus retinitis). ASOs offer a unique ability to target specific RNA sequences and help overcome limitations associated with traditional therapies.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
Experimental RNAi
Small interfering RNAs (siRNA)
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

